md-medicaldata

Authors

 

Kristina Kalmar¹, Ivana Mudrinić¹, Aleksandra Cvetinović¹, Jovana Krasić¹, Rastislava Krasnik^1,2, Jelena Zvekić-Svorcan<sup>1,3

1</sup>Medicinski fakultet Novi Sad, Univerzitet u Novom Sadu, Republika Srbija
²Institut za zdravstvenu zaštitu dece i omladine Novi Sad, Republika Srbija
³Specijalna bolnica za reumatske bolesti Novi Sad, Republika Srbija

 

UDK: 616-002.77-06
613.7

The paper was received / Rad primljen: 05.02.2024

Accepted / Rad prihvaćen: 21.02.2024.

 

Correspondence to:

Doc. Dr Jelena Zvekić-Svorcan
Medicinski fakultet, Univerzitet u Novom Sadu,
Specijalna bolnica za reumatske bolesti
Novi Sad Futoška 68, 21 000 Novi Sad, Republika Srbija
e-mail: jelena.zvekic-svorcan@mf.uns.ac.rs

 

 

Sažetak

 

 

Uvod: Osteoartroza (OA) je hronična bolest zglobova koja se karakteriše degeneracijom zglobne hrskavice, okolne kosti i drugih vanzglobnih struktura. Postoje znatni dokazi za prednosti koje proističu iz fizičke aktivnosti kod OA. Cilj: Ispitati uticaj komorbiditeta na fizičku aktivnost i zamor kod pacijenata koji boluju od degenerativnog reumatizma. Materijal i metode: Prospektivna studija preseka je obuhvatila 51 ispitanika oba pola, starosti 18-65 godina, obolelih od degenerativnog reumatizma, lečenih u Specijalnoj bolnici za reumatske bolesti u Novom Sadu. Svi ispitanici su potpisali informisani pristanak i popunili opšti upitnik o sociodemografskim podacima, koji je sastavljen od strane ispitivača. Takođe, svi ispitanici su popunili Fatigue Severity Scale i International Physical Activity Questionnaire. Statistička obrada i analiza odrađena je u statističkom paketu SPSS ver. 24 (Statistical Package for the Social Sciences) for Windows. Rezultati: Prosečna starost ispitanika je iznosila 55,33 godina sa predominacijom ženskog pola (74,5%). Komorbiditeti su prisutni kod 64,7% ispitanika, gde hipertenzija predstavlja najučestaliji komorbiditet (58,8%). Prosečna ostvarena vrednost na skali zamora iznosi 30,82±12,33, što ukazuje na osrednji nivo zamora ispitanih pacijenata. Prisustvo komorbiditeta je statistički značajni prediktor intenziteta zamora (Beta=0,949, p=0,032). Od ispitanih komorbiditeta, statistički značajan uticaj na osećaj zamora ima hipertenzija (Beta=0,890, p=0,040). Više od polovine ispitanih pacijenata (58,8%) je na niskom nivou fizičkih aktivnosti. Na intenzitet fizičke aktivnosti ne utiče kako ni prisustvo komorbiditeta, tako ni vrsta komorbiditeta, što pokazuje Univarijantna linearna regresija. Statistička značajnost beta koeficijenta iznad je vrednosti od p≤0,05. Zaključak: Ispitanici koji boluju od degenerativnog reumatizma imaju hipertenziju kao najčešći komorbiditet. Prisustvo komorbiditeta dovodi do većeg nivoa zamora kod pacijenata, a na intenzitet fizičke aktivnosti ne utiče ni prisustvo ni vrsta komorbiditeta.

 

Ključne reči:

degenerativni reumatizam; osteoartroza; komorbiditet; zamor; fizička aktivnost

 

 

 

Abstract

 

Introduction: Osteoarthritis (OA) is a chronic joint disease characterized by the degeneration of articular cartilage, surrounding bones, and other extra-articular structures. There is substantial evidence for the benefits of physical activity in osteoarthritis. The Aim: The aim of this study was to investigate the impact of comorbidities on physical and fatigue in patients suffering from degenerative rheumatism. Materials and Methods: A prospective cross-sectional study that included 51 patients of both genders, aged 18-65 years, diagnosed with degenerative rheumatism and receiving treatment at the Special Hospital for Rheumatic Diseases in Novi Sad. All respondents signed an informed consent form and filled out a general questionnaire on socio-demographic data, which the examiner compiled. Also, all respondents completed the Fatigue Severity Scale and the International Physical Activity Questionnaire. Statistical processing and analysis were done using the statistical package SPSS ver. 24 (Statistical Package for the Social Sciences) for Windows. Results: The average age of the respondents was 55.33 years, with a predominance of women (74.5%). Comorbidities are present in 64.7% of respondents, where hypertension is the most common comorbidity (58.8%). The average achieved value on the fatigue scale is 30.82±12.33, which indicates the average level of fatigue of the examined patients. Comorbidities are a statistically significant predictor of fatigue intensity (Beta=0.949, p=0.032). Of the examined comorbidities, hypertension has a statistically significant effect on the feeling of fatigue (Beta=0.890, p=0.040). More than half of the examined patients (58.8%) are at a low level of physical activity. Univariate linear regression shows that neither comorbidity nor the type of comorbidity affects the intensity of physical activity. The statistical significance of the beta coefficient is above the value of p≤0.05. Conclusion: Respondents suffering from degenerative rheumatism have hypertension as the most common comorbidity. The presence of comorbidity leads to a higher level of fatigue in patients, and the intensity of physical activity is not affected by the presence or type of comorbidity.

 

Key words:

degenerative rheumatism; osteoarthritis; comorbidity; fatigue; physical activity

 

 

 

 

References:

1. Boskovic K. Osteoarthritis - Etiopathogenesis and review of new knowledge, importance of early diagnosis. Med Pregl. 2022;75(2):37–42.
2. AlAjmi, M, Al-Ghamdi, S. Translation and validation of the Arabic version of the osteoarthritis quality of life questionnaire (OAQoL) in Saudi patients with osteoarthritis. Health Qual Life Outcomes. 2021;19(91). doi: https://doi.org/10.1186/s12955-021-01741-9
3. Molnar V, Matišić V, Kodvanj I, Bjelica R, Jeleč Ž, Hudetz D, et al. Cytokines and chemokines involved in osteoarthritis pathogenesis. International Journal of Molecular Sciences. 2021;22(17):9208.
4. Roman-Blas JA, Mendoza-Torres LA, Largo R, Herrero-Beaumont G. Setting up distinctive outcome measures for each osteoarthritis phenotype. Therapeutic Advances in Musculoskeletal Disease. 2020;12:1-16.
5. Castrogiovanni P, Di Rosa M, Ravalli S, Castorina A, Guglielmino C, Imbesi R, et al. Moderate physical activity as a prevention method for knee osteoarthritis and the role of synoviocytes as biological key. International Journal of Molecular Sciences. 2019;20(3):511.
6. Berberski N, Krasić J, Cvetinović A, Tatić A, Bošković K, Zvekić-Svorcan J. Efekat Horizontalne terapije na aktivnosti u svakodnevnom životu kod pacijenata sa lumbalnimsindromom. MD Medical Data 2023;15(3):73-78.
7. Nikolova V, Prakova G. Degenerative joint diseases (osteoartrosis) and quality of life. Trakia Journal of Sciences. 2018;16(1):180-183.
8. Tatić A, Cvetinović A, Krasić J, Berberski N, Bošković K, Zvekić-Svorcan J. Uticaj fizikalne terapije na bol i zamor kod pacijenata sa reumatoidnim artritisom. MD Medical Data 2023;15(3):85-88.
9. Krasić J, Berberski N, Cvetinović A, Tatić A, Bošković K, Zvekić-Svorcan J. Efekat Horizontalne terapije na bol i onesposobljenost kod pacijenata sa lumbalnim sindromom. MD Medical Data 2023;15(3):79-84.
10. Cvetinović A, Tatić A, Krasić J, Berberski N, Bošković K, Zvekić-Svorcan J. Prediktori zamora kod pacijenata sa reumatoidnim artritisom. MD Medical Data 2023;15(3):89-94.
11. Valko OP, Bassetti LC, Bloch EK, Held U, Baumann RC. Validation of the Fatigue Severity Scale in a Swiss Cohort. SLEEP 2008;31(11):1601-1607.
12. Cleland C, Ferguson S, Ellis G, Hunter RF. Validity of the International Physical Activity Questionnaire (IPAQ) for assessing moderate-to-vigorous physical activity and sedentary behaviour of older adults in the United Kingdom. BMC Medical Research Methodology. 2018;18(1). doi:10.1186/s12874-018-0642-3
13. Tschon M, Contartese D, Pagani S, Borsari V, Fini M. Gender and sex are key determinants in osteoarthritis not only confounding variables. A systematic review of Clinical Data. Journal of Clinical Medicine. 2021;10(14):3178.
14. Zhang Y, Wang J, Liu X. Association between hypertension and risk of knee osteoarthritis. Medicine. 2017;96(32). doi:10.1097/md.0000000000007584
15. Rehling T, Bjørkman AD, Andersen MB, Ekholm O, Molsted S. Diabetes Is Associated with Musculoskeletal Pain, Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis. J Diabetes Res. 2019;2019:6324348.
16. Demmelmaier I, Pettersson S, Nordgren B, Dufour AB, Opava CH. Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis. Rheumatology International. 2018;38(11):2147–2155.
17. Esbensen BA, Stallknecht SE, Madsen ME, Hagelund L, Pilgaard T. Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis. PLOS ONE. 2020;15(8). doi:10.1371/journal.pone.0237117
18. Nikolaus S, Bode C, Taal E, van de Laar MA. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken). 2013;65(7):112846.
19. Tournadre A, Pereira B, Gossec L, Soubrier M, Dougados M. Impact of comorbidities onfatigue in rheumatoid arthritis patients: Results from a nurse-led program for Comorbidities Management (COMEDRA). Joint Bone Spine. 2019;86(1):55–60.
20. Zvekic-Svorcan J, Minakovic I, Vojnovic M, Miljkovic A, Mikov J, Boskovic K. The role of metabolic syndrome in the development of osteoarthritis. Med Pregl. 2022;75(1–2):39– 43.
    

PDF: 05-Kalmar K. et al. MD-Medical Data 2023;16(1) 037-041.pdf